An update on new and emerging therapies for cystic fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An update on new and emerging therapies for cystic fibrosis

Published:2017-10-02 Issue:4 Volume:22 Page:331-346
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Hudock Kristin M.¹²,Clancy John Paul³

Affiliation:

1. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA

2. Division of Pulmonary Biology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

3. Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

Funder

Cystic Fibrosis Foundation

National Institutes of Health

Parker B. Francis Foundation

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2017.1418324

Reference147 articles.

1. Cystic fibrosis

2. Dorothy Hansine Andersen

3. The Influence of Genetics on Cystic Fibrosis Phenotypes

4. Epidemiology of Cystic Fibrosis

5. Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effets indésirables de l’association tezacaftor/ivacaftor/elexacaftor pouvant mener à un arrêt de traitement : à propos d’une série de 10 cas;Therapies;2024-07

2. OrgaSegment: deep-learning based organoid segmentation to quantify CFTR dependent fluid secretion;Communications Biology;2024-03-13

3. In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells;iScience;2023-11

4. CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare CFTR Genotypes;International Journal of Molecular Sciences;2023-09-26

5. Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation;Journal of Cystic Fibrosis;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3